Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 4,761 Jan 1 – Oct 26, 2026
- Disclosed funding
- $346.8B 3697 disclosed amounts
- Median round
- $14.5M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| RA Provides AI for running and operating software in production | $40M | Series A+Series A | Enterprise software | United States | Investors | |
FactoryCompany profile Develops an autonomous software-development platform for enterprise engineering teams. Develops an autonomous software-development platform for enterprise engineering teams. | $150M | Series CSeries C+ | AI | United States | Investors | |
| N Nas.comCompany profile AI platform for solopreneurs to build businesses, create products, and find customers AI platform for solopreneurs to build businesses, create products, and find customers | $27M | Series A | AI | United States | Investors | |
| T Develops circadian technology products for jet lag and shift work | Undisclosed | Undisclosed | Healthtech | United States | Investors | |
| DI Delta IntelligenceCompany profile Delta Intelligence develops foundation models and data-collection tools for humanoid robots to understand space and coordinate whole-body movement. Delta Intelligence develops foundation models and data-collection tools for humanoid robots to understand space and coordinate whole-body movement. | Undisclosed | First financingUndisclosed | Robotics | China | Investors Undisclosed | |
| E Develops energy-efficient AI processing for real-time edge inference | Undisclosed | Series B+Series B | Hardware | Japan | Investors | |
| P Builds an AI Supercloud for deploying and scaling AI agents | $32M | Series A | AI | United States | Investors | |
| TB Terremoto BiosciencesCompany profile Develops highly targeted, small molecule medicines for cancer and rare diseases Develops highly targeted, small molecule medicines for cancer and rare diseases | $108M | Series CSeries C+ | Biotech | United States | Investors | |
| H Builds revenue intelligence platform with AI agents for enterprise sales | Undisclosed | Undisclosed | Enterprise software | United States | Investors | |
| CE Cadre Energy SolutionsCompany profile Provides contract natural gas compression services to upstream and midstream operators Provides contract natural gas compression services to upstream and midstream operators | Undisclosed | StrategicUndisclosed | Climate tech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
BioStack, Tractian, Blacksmith
161rounds5led - 2Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
112rounds22led - 3General Catalyst
Matiks, Provision Labs, Tractian
103rounds13led - 4Lightspeed
Warp Sciences, Different, Zenzap
80rounds9led - 5Sequoia Capital
Nevis, Warhound, Whop
73rounds13led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →